Acoustic Radiation Force Impulse Imaging (ARFI) in Patients After Liver Transplantation
|ClinicalTrials.gov Identifier: NCT01664780|
Recruitment Status : Unknown
Verified August 2012 by University of Erlangen-Nürnberg Medical School.
Recruitment status was: Recruiting
First Posted : August 14, 2012
Last Update Posted : August 14, 2012
Aims: Prospective evaluation of the applicability of acoustic radiation force impulse(ARFI) imaging to assess liver fibrosis in patients after orthotopic liver transplantation.
Material and methods: We prospectively assess the performance of ARFI imaging in planned 100 patients after orthotopic liver transplantation. We evaluate shear wave velocity of the left and right liver lobe with the convex array (6C1HD)ultrasound transducer and compare the results with clinical data and B-mode criteria.
ARFI elastometry is an increasingly popular non-invasive method for the assessment of hepatic fibrosis and cirrhosis. To date, ARFI technology has not been applied systematically in patients after orthotopic liver transplantation. Therefore we want to establish standard values in this population.
|Condition or disease||Intervention/treatment|
|Liver Transplantation||Device: ARFI imaging|
|Study Type :||Observational|
|Estimated Enrollment :||100 participants|
|Official Title:||Acoustic Radiation Force Impulse Imaging (ARFI) in Patients After Liver Transplantation|
|Study Start Date :||May 2012|
|Estimated Primary Completion Date :||December 2014|
|Estimated Study Completion Date :||December 2014|
|Patients after liver transplantation||Device: ARFI imaging|
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01664780
|University Hospital of Erlangen, Dep. of Medicine 1||Recruiting|
|Erlangen, Germany, 91054|
|Contact: Dane Wildner, MD 0049 9131 8535250 firstname.lastname@example.org|
|Contact: Steffen Zopf, MD 0049 9131 8535250 steffen.Zopf@uk-erlangen.de|
|Sub-Investigator: Deike Strobel, MD|
|Principal Investigator: Dane Wildner, MD|
|Principal Investigator: Steffen Zopf, MD|
|Principal Investigator:||Dane Wildner, MD||Dep. of Medicine 1, University of Erlangen-Nuremberg|